Skip to main content

Table 2 Characteristics of included studies

From: Decompressive craniectomy for malignant middle cerebral artery infarctions: a meta-analysis

 

Study design

No. of patients

(DC/total)

Age

(Mean ± SD)

Sex

(Male/Female)

Time to treatment

Duration of follow-up

NIHSS

DECIMAL 2007 [13]

RCT

20/38

43.5 ± 9.7

9/11

12–36 h

6, 12

22.5 (16–35)

43.3 ± 7.1

9/9

23.4 (17–38)

DESTINY 2007 [14]

RCT

17/32

43.2 ± 9.7

8/9

12–36 h

6, 12

21 (19–26)

46.1 ± 8.4

7/8

24 (19–31)

DESTINY II 2014 [15]

RCT

49/112

70 (62–82)

25/24

<48 h

6, 12

20 (15–40)

70 (61–80)

31/32

21 (15–38)

HAMLET [16]

RCT

32/64

50.0 ± 8.3

20/12

<96 h

3, 6, 12

23 (17–34)

47.4 ± 9.8

18/14

24 (20–36)

HAMLET II [17]

RCT

32/64

50.0 ± 8.3

20/12

<96 h

3, 6, 12, 36

23 (17–34)

47.4 ± 9.8

18/14

24 (20–36)

HeADDFIRST [18]

RCT

14/24

52.3 (45–59)

9/5

<96 h

6

N/A

57.9 (45–66)

6/4

Slezins 2012 [19]

RCT

11/24

57.2 (49–81)

N/A

<48 h

12

21.2 (16–28)

65.0 (49–81)

20.8 (17–24)

Zhao 2012 [20]

RCT

24/47

63.5 (29–78)

6/18

<48 h

6, 12

N/A

64.0 (32–80)

7/16

Mohammed 2014 [21]

R

90/125

53.8 ± 7.1 (34–35)

N/A

<24 h

3, 6

N/A

Rai 2014 [22]

P

36/60

44.3 ± 12.23

27/16

<148 h

3, 6, 12

19.0 ± 3.3

57.12 ± 19.28

18.4 ± 3.8

Tsai 2012 [23]

P

37/79

65.5 ± 15.8

18/19

<48 h

6

N/A

75.9 ± 13.8

22/20

Yang 2015 [24]

R

10/24

58.7 ± 19.3

5/5

120 h

3

16.1 ± 1.9

65.9 ± 16.5

10/4

16.5 ± 2.4

Yu 2012 [25]

R

58/131

62.1 ± 12.4

35/23

<48 h

6

16.2

72.6 ± 9.4

36/37

16.8

Rahamnian 2014 [26]

P

30/60

59.0 ± 13.5

22/29

<48 h

3

N/A

62.1 ± 11.0

16.14

  1. R Retrospective, P Prospective, DECIMAL decompressive craniectomy in malignant middle cerebral artery infarction, DESTINY Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery, HAMLET Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke, HeADDFIRST Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial